Zekiye Altun Selected Research

Zekiye Altun Research Topics

Disease

14	Neoplasms (Cancer) 01/2024 - 01/2010
11	Neuroblastoma 11/2023 - 01/2010
9	Ototoxicity 08/2020 - 01/2011
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2024 - 02/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 02/2017
2	Adenocarcinoma of Lung 01/2024 - 02/2017
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023 - 01/2020
2	Necrosis 09/2022 - 04/2015
2	Breast Neoplasms (Breast Cancer) 07/2021 - 09/2015
2	Cardiotoxicity 08/2020 - 10/2016
1	Large Cell Carcinoma 01/2024
1	Non-Muscle Invasive Bladder Neoplasms 11/2023
1	Neoplasm Metastasis (Metastasis) 09/2023
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2021
1	Retinal Detachment (Retinal Detachments) 01/2019
1	Macular Edema 01/2019
1	Ganglioneuroma 10/2018
1	Adenocarcinoma 02/2017
1	Lung Neoplasms (Lung Cancer) 02/2017
1	Carcinoma (Carcinomatosis) 02/2017
1	Protein-Energy Malnutrition (Marasmus) 06/2014
1	Malnutrition (Nutritional Deficiencies) 06/2014
1	Hypoxia (Hypoxemia) 01/2010
1	Asthma (Bronchial Asthma) 03/2007
1	Inflammation (Inflammations) 03/2007

Drug/Important Bio-Agent (IBA)

12	Cisplatin (Platino)FDA LinkGeneric 09/2022 - 01/2010
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2014
5	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2010
3	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2021 - 01/2010
3	Acetylcarnitine (Alcar)IBA 08/2020 - 01/2011
2	ParaffinIBA 01/2023 - 01/2019
2	lipoplatinIBA 09/2022 - 08/2018
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 01/2010
2	AntioxidantsIBA 08/2020 - 09/2006
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2019
2	ResveratrolIBA 07/2015 - 03/2014
2	sanguinarineIBA 04/2015 - 01/2014
1	LigandsIBA 01/2024
1	Programmed Cell Death 1 ReceptorIBA 01/2024
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 11/2023
1	TOR Serine-Threonine KinasesIBA 11/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2023
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 09/2023
1	Fluorouracil (Carac)FDA LinkGeneric 09/2023
1	4-O-carboxymethylascochlorinIBA 01/2023
1	Formaldehyde (Formol)FDA Link 01/2023
1	Anaplastic Lymphoma KinaseIBA 01/2023
1	Biotin (Vitamin H)FDA Link 09/2022
1	Cytostatic AgentsIBA 09/2022
1	dinutuximabIBA 01/2022
1	liposomal doxorubicin (Doxil)FDA Link 07/2021
1	Liposomes (Liposome)IBA 07/2021
1	Asparaginase (Elspar)FDA Link 01/2021
1	Eicosapentaenoic AcidIBA 01/2021
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2021
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021
1	Oxidants (Oxidizing Agents)IBA 08/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 08/2020
1	Hematoxylin (Haematoxylon)IBA 08/2020
1	superoxide dismutase 2IBA 08/2020
1	Caspase 3 (Caspase-3)IBA 08/2020
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2020
1	NitritesIBA 08/2020
1	OxidesIBA 08/2020
1	Protective AgentsIBA 08/2020
1	ChemokinesIBA 01/2020
1	Interleukin-2 (IL2)IBA 01/2020
1	CytokinesIBA 01/2020
1	Ciliary Neurotrophic Factor (CNTF)IBA 01/2020
1	Chitinase-3-Like Protein 1IBA 01/2019
1	Retinaldehyde (Retinal)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 10/2018
1	ChaperoninsIBA 02/2017
1	PolyphenolsIBA 12/2016
1	AminoglycosidesIBA 11/2016
1	Annexin A5IBA 04/2015
1	Transferrin (beta 2 Transferrin)IBA 06/2014
1	Insulin-Like Growth Factor I (IGF-1)IBA 06/2014
1	IronIBA 06/2014
1	Protein Isoforms (Isoforms)IBA 06/2014
1	Vincristine (Oncovin)FDA LinkGeneric 01/2010
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2010
1	GelatinasesIBA 01/2010
1	Etoposide (VP 16)FDA LinkGeneric 01/2010
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2010
1	Tissue Inhibitor of Metalloproteinase-2IBA 01/2010
1	Cytotoxins (Cytolysins)IBA 01/2010
1	Indicators and Reagents (Reagents)IBA 01/2010
1	Immunoglobulin E (IgE)IBA 03/2007
1	SteroidsIBA 03/2007
1	Cell Adhesion MoleculesIBA 03/2007

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 09/2023 - 10/2018
4	Immunotherapy 11/2023 - 01/2020
4	Therapeutics 01/2023 - 03/2007
1	Lymph Node Excision (Lymph Node Dissection) 01/2024
1	Hyperthermic Intraperitoneal Chemotherapy 09/2023
1	Parenteral Infusions 09/2023
1	Microbubbles 07/2021
1	Lasers (Laser) 02/2017
1	Oral Administration 03/2014